The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
- 22 September 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (43), 10267-10274
- https://doi.org/10.1021/bi9009677
Abstract
Wnt proteins bind to seven-transmembrane Frizzled receptors to mediate the important developmental, morphogenetic, and stem cell related tissue-regenerative effects of Wnt signaling. Dysregulated Wnt signaling is associated with many cancers. Currently, there are no drug candidates or even tool compounds that modulate Wnt-mediated receptor trafficking, and subsequent Wnt signaling. We examined libraries of FDA-approved drugs for their utility as Frizzled internalization modulators, employing a primary imaged-based GFP fluorescence assay that uses Frizzled1 endocytosis as the readout. We now report that the anti-helminthic niclosamide, a drug used for the treatment of tapeworm, promotes Frizzled1 endocytosis, downregulates Dishevelled-2 protein, and inhibits Wnt3A-stimulated β-catenin stabilization and LEF/TCF reporter activity. Additionally, following niclosamide-mediated internalization, the Frizzled1 receptor colocalizes in vesicles containing transferrin and agonist-activated β2-adrenergic receptor. Therefore, niclosamide may serve as a negative modulator of Wnt/Frizzled1 signaling by depleting upstream signaling molecules (i.e., Frizzled and Dishevelled) and moreover may provide a valuable means of studying the physiological consequences of Wnt signaling.Keywords
This publication has 21 references indexed in Scilit:
- A Wnt Survival Guide: From Flies to Human DiseaseJournal of Investigative Dermatology, 2009
- Wnt signalling in development and diseaseEMBO Reports, 2008
- Postsynaptic Positioning of Endocytic Zones and AMPA Receptor Cycling by Physical Coupling of Dynamin-3 to HomerNeuron, 2007
- Small-molecule synergist of the Wnt/β-catenin signaling pathwayProceedings of the National Academy of Sciences of the United States of America, 2007
- Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor ContextPLoS Biology, 2006
- Identification of a Specific Inhibitor of the Dishevelled PDZ DomainBiochemistry, 2005
- Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptorsMolecular and Cellular Neuroscience, 2005
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Synthetic small molecules that control stem cell fateProceedings of the National Academy of Sciences of the United States of America, 2003
- β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptorNature, 1996